From: Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences
RT-PCR
ISH
Total
IGF2-P4
38/39
24/28
62/67
H19
37/39
27/28
64/67